Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Tel: 01939 211200 XENO® 50-MINI SPOT-ON SOLUTION FOR Special warnings: Do not overdose. TOPICAL ADMINISTRATION
If you are uncertain about the condition of your pet,
Small Animal Exemption Scheme (SAES) product
If symptoms persist, consult a veterinary surgeon. Qualitative and quantitative composition 1 pipette contains: Active substance: Ivermectin 50 μg Special precautions to be taken by the person admin-Pharmaceutical form Clinical particulars
system disorders, lethargy, inappetance, local irrita-
rats, hamsters, mice, gerbils, chinchillas and other
tion and/or hypersensitivity reactions may be ob-
small rodents up to 1250 g body weight, and birds
served. These signs may be more common in young
animals. Should such a reaction occur, discontinueuse and seek veterinary advice.
If you notice any serious effects or other effects not
dal spot-on solution. A simple and effective spot-on
mentioned in this data sheet, please inform your
solution for prevention and treatment of common
internal and external parasites of small mammals andbirds. Applied to the skin, Xeno 50-mini is absorbed
Amounts to be administered and administration
into the body and is particularly effective against the
Topical insecticidal and acaricidal spot-on
parasites which commonly cause ear disease in the
rabbit and ferret, and the mites that cause skin
Each pipette contains 50 μg ivermectin. Each pi-
disease in guinea pigs, rabbits and rodents, including
pette contains approximately 15 drops. Each drop will
mange in guinea pigs and the condition known as
deliver approximately 3.3 micrograms ivermectin.
walking dandruff in rabbits. It is also effective against
Do not overdose. In order to apply a correct dosage
many of the parasites which cause skin and feather
it is essential to accurately weigh the animal. Your
veterinary practice can help you to do this.
The active substance ivermectin is a substance
known as an endectocide because it kills parasites
Holding the pipette firmly in one hand, twist off the
that cause infestation inside the body (endoparasites)
as well as those living outside the body, on the skin
Mammals: Using the dosage table, apply the cor-
(ectoparasites). Ivermectin is used in many species
rect number of drops or pipettes onto the skin on the
for the control of mites, roundworms and lice.
back of the neck and down the spine.
Birds: Apply 1 drop (3.3 μg) per 15 g body weight
under the feathers onto the skin of the back between
those indicated. Serious reactions, including deaths,
the wings. For larger body weight birds apply 1
have been reported in dogs (especially Collies, Old
English Sheepdogs and related breeds), tortoises and
For routine prevention of common ectoparasites
turtles treated with products containing the active
this dose should be repeated monthly. For the
treatment of an existing infestation, repeat doses are
This product is toxic to chelonians. Do not use in
required two weeks and four weeks after the initial
tortoises, turtles or related species. XENO 50-Mini Spot on Dosage Guidelines Body weight (g) Amount to use Pipette(s)
on animals intended for human consumption. Do not
This product is not effective against ringworm.
Ringworm is a skin disease which can be passed onfrom your pet to humans. If you think your pet may
Pharmaceutical particulars
have ringworm, you should consult a veterinary
sight and reach of children. Do not store above 25˚C.
For any information about this veterinary medicinal
product, please contact the distributor. Date of last review: September 2013
propylene tubes, each of 50 μg ivermectin. Legal category SAES
pipettes immediately following use. Dispose of wastematerials in accordance with local requirements. GTIN (Global Trade Item No) Further information Manufacturer’s authorisation
Xeno 50-Mini Spot-on Solution for Topical Adminis-
Requested by: lynne.easton@dechra.com Approved datasheets found: 1 Creation date: 14/10/2013 15:27:34 (UK) Approved for book but not on website: 0 Datasheets marked as draft (ignored): 0
Xeno 50-Mini Spot-on Solution for Topical
For pet animals only. Do not use in animals
intended for human consumption. Do not eat eggsfrom treated birds. Directory of participants Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Tel: 01939 211200Fax: 01939 211201email: info.uk@dechra.comwww.dechra.com
LIST OF PRODUCTS BY THERAPEUTIC INDICATION
List of Products by Therapeutic Indication PHARMACEUTICALS Endectocides Ectoparasiticides For companion animals
Xeno 50-Mini Spot-on Solution for Topical
Xeno 50-Mini Spot-on Solution for Topical
For rabbits Endoparasiticides
Xeno 50-Mini Spot-on Solution for Topical
Xeno 50-Mini Spot-on Solution for Topical
Anthelmintics for Rabbits
Xeno 50-Mini Spot-on Solution for Topical
List of Products by Species
Please note that a species in brackets after a product name may not necessarily be a part of that product namebut is intended to make the index easier to use.
Xeno 50-Mini Spot-on Solution for Topical
Xeno 50-Mini Spot-on Solution for Topical
Ornamental birds Xeno 50-Mini Spot-on Solution for Topical Small mammals
Xeno 50-Mini Spot-on Solution for Topical
Xeno 50-Mini Spot-on Solution for Topical
List of Products by Active Ingredients
This index of non-proprietary names (active ingredients) is provided to enable users of the Compendium toidentify the brand names of relevant products when only the non-proprietary names are known.
It should be noted that although different products may contain the same active ingredient this does not implythat they are equivalent in regard to bioavailability or therapeutic activity.
Some products contain a number of ingredients and it has not been possible in every instance to identify suchproducts by a reference in this index to each ingredient.
Non-proprietary name in bold type. Proprietary name in ordinary type. Ivermectin
Xeno 50-Mini Spot-on Solution for Topical
GRED IN E IV Alphabetical Index of Products
Chapter 22 Solutions 22.1. (a) Diagram below. (b) The null hypothesis is “all groups have the same mean rest period,” and the alternative is “at least one group has a different mean rest period.” The P -value shows significant evidence against H 0, and the graph leads us to conclude that caffeine has the effect of reducing the length of the rest period. Note: Students mig